Maladie de Horton non compliquée : traitement initial par trois bolus de 500 mg de méthylprednisolone suivis de 20 mg/j d’équivalent-prednisone. Évaluation chez 15 patients
L. Sailler(Université Fédérale de Toulouse Midi-Pyrénées), P. Arlet(Centre de Référence Déficits Immunitaires Héréditaires), Marco Klinger(University of Milan), M. Carreiro, Pierre Delobel, D Ferrand(Hôpital Rangueil), S. Ollier(Institut universitaire du cancer de Toulouse Oncopole), H. Juchet(Hôpital Rangueil)
Cited by 19
Related Papers
Further characterization of clinical and laboratory features in VEXAS syndrome: large‐scale analysis of a multicentre case series of 116 French patients*
|British Journal of Dermatology|2021|414
Autoimmune and inflammatory manifestations occur frequently in patients with primary immunodeficiencies
|Journal of Allergy and Clinical Immunology|2017|316
Hydroxychloroquine in systemic lupus erythematosus: results of a French multicentre controlled trial (PLUS Study)
|Annals of the Rheumatic Diseases|2012|207
Determinants of Hydroxychloroquine Blood Concentration Variations in Systemic Lupus Erythematosus
|Arthritis & Rheumatology|2015|140
Risk factors for bleeding, including platelet count threshold, in newly diagnosed immune thrombocytopenia adults
|Journal of Thrombosis and Haemostasis|2018|138